谷歌浏览器插件
订阅小程序
在清言上使用

Progression-Free Survival and Patterns of Response in Patients with Relapsed High-Risk Neuroblastoma Treated with Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor

JOURNAL OF CLINICAL ONCOLOGY(2023)

引用 14|浏览85
关键词
Neuroblastoma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要